Editorial Board
Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.
Editor-in-Chief
Michael T. Lotze, MD
University of Pittsburgh, United States
orcid.org/0000-0003-3988-5419
Declaration of Interests

Deputy Editor-in-Chief
Sjoerd H. van der Burg, PhD
Oncode Institute & Leiden University Medical Center, Netherlands
Declaration of Interests
Basic and Translational Cancer Immunology
Section Editor
Claudia Palena, PhD
National Cancer Institute, National Institutes of Health, United States
Walter J. Storkus, PhD
University of Pittsburgh, United States
Eric Tartour, MD, PhD
Hôpital Européen Georges Pompidou, France
Deputy Editor
Hongbo Hu, PhD
West China Hospital, Sichuan University, China
Associate Editors
Scott I. Abrams, PhD
Roswell Park Comprehensive Cancer Center, United States
Timothy NJ Bullock, PhD
University of Virginia, United States
orcid.org/0000-0001-6141-3261
Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena, Italy
orcid.org/0000-0003-2851-8605
Jennifer L. Guerriero, PhD
Brigham and Women’s Hospital, United States
orcid.org/0000-0002-2104-5457
Tanja D. de Gruijl, PhD
Amsterdam University Medical Centers, the Netherlands
orcid.org/0000-0003-1464-8978
Pawel Kalinski, MD, PhD
Roswell Park Comprehensive Cancer Center, United States
Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine, United States
Sattva S. Neelapu, MD
The University of Texas MD Anderson Cancer Center, United States




Anna Obenauf, PhD
Research Institute of Molecular Pathology, Austria
Michael Platten, MD
Ruprecht-Karls University Heidelberg, Germany
orcid.org/0000-0002-4746-887X
Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME), Argentina
orcid.org/0000-0002-0947-8735
Alessandro Russo, MD, PhD
Università degli Studi di Messina, Italy
Stefani Spranger, PhD
Massachusetts Institute of Technology, United States
Viktor Umansky, PhD
German Cancer Research Center (DKFZ), Germany
Louis M. Weiner, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States
orcid.org/0000-0001-5192-0710



Case Reports
Section Editor
Sebastian Kobold, MD
Klinikum der Universität München, Germany
Associate Editors
Jack D. Bui, MD, PhD
University of California San Diego, United States
orcid.org/0000-0002-9324-368X
Marco Donia, MD, PhD
National Center for Cancer Immune Therapy, Denmark
orcid.org/0000-0003-4966-9752


Heinz Läubli, MD, PhD
University Hospital Basel, Switzerland
orcid.org/0000-0002-8910-5620
Allison Betof Warner, MD, PhD
Stanford Cancer Center, United States
Clinical Cancer Immunotherapy
Section Editors
Jason J. Luke, MD, FACP
University of Pittsburgh Medical Center, United States
orcid.org/0000-0002-1182-4908

Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center, United States
orcid.org/0000-0003-1471-6723

Associate Editors
Paolo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione ‘G.Pascale’, Italy
orcid.org/0000-0002-8322-475X
Tina Cascone, MD, PhD
The University of Texas MD Anderson Cancer Center, United States
Margaret E. Gatti-Mays, MD, MPH
Ohio State University Comprehensive Cancer Center, United States
orcid.org/0000-0001-8914-2897
Francois Ghiringhelli, PhD
Institut National De La Sante Et De Le Recherche Medicale (INSERM), France
James J. Harding, MD
Memorial Sloan Kettering Cancer Center, United States
Douglas B. Johnson, MD, MSCI
Vanderbilt University Medical Center, United States


Yangqiu Li, MD
Jinan University School of Medicine, China
Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health, United States
orcid.org/0000-0001-5106-8636
Luca Mazzarella, MD, PhD
European Institute of Oncology, Italy
orcid.org/0000-0002-4043-3279
Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center, United States
Ravi Patel, MD, PhD
University of Pittsburgh, United States
orcid.org/0000-0002-8328-746X



Commentary/Editorials
Section Editor
Christian M. Capitini, MD
University of Wisconsin, Madison, United States
orcid.org/0000-0002-2276-6731

Associate Editors
Ana Carrizosa Anderson, MD
Harvard University, United States
orcid.org/0000-0002-0877-2932
Diwakar Davar, MD
UPMC Hillman Cancer Center, United States

Michael Dougan, MD, PhD
Massachusetts General Hospital, United States
William J. Murphy, PhD
University of California, Davis, United States
orcid.org/0000-0002-2793-401X

Guidelines and Consensus Statements
Section Editor
Robert L. Ferris, MD, PhD
UNC Lineberger Comprehensive Cancer Center, United States
orcid.org/0000-0001-6605-2071

Immune Cell Therapies and Immune Cell Engineering
Section Editor
Aude Chapuis, MD
Fred Hutchinson Cancer Research Center, United States
Marcela V. Maus, MD, PhD
Massachusetts General Hospital, United States
Associate Editors
Marco L. Davila, MD, PhD
Roswell Park Comprehensive Cancer Center, United States
orcid.org/0000-0002-6270-3065
Joseph A. Fraietta, PhD
University of Pennsylvania, United States
orcid.org/0000-0001-7900-8993
Sara Ghorashian, MD, PhD
University College London, United Kingdom
orcid.org/0000-0002-1555-2946
Michael Hudecek, MD
Universitätsklinikum Würzburg, Germany
Michael D. Kalos, PhD
Next Pillar Consulting, United States
Gerald Linette, MD, PhD
University of Pennsylvania, United States
orcid.org/0000-0001-6147-6115
Daniel J. Powell, Jr., PhD
University of Pennsylvania, United States
orcid.org/0000-0002-5966-8908





Marco Ruella, MD
University of Pennsylvania, United States
orcid.org/0000-0003-4301-5811
Lillian Seu, PhD
Revolution Medicines, United States
orcid.org/0000-0002-8456-019X
Nirali N. Shah, MD, MHSc
National Cancer Institute, National Institutes of Health, United States
orcid.org/0000-0002-8474-9080
Eric L. Smith, MD, PhD
Dana-Farber Cancer Institute, United States
orcid.org/0000-0002-0296-7587
Maria Themeli, MD, PhD
VUmc Cancer Center Amsterdam, the Netherlands




Immunotherapy Biomarkers
Section Editor
Ignacio Melero, MD, PhD
University of Navarra, Spain
orcid.org/0000-0002-1360-348X
Kurt Schalper, MD, PhD
Yale School of Medicine, United States

Alexandra Snyder Charen, MD
Generate Biomedicines, United States
orcid.org/0000-0002-2606-3523

Associate Editors
Valsamo Anagnostou, MD, PhD
Johns Hopkins University, United States
Carlos de Andrea, MD, PhD
University of Navarra, Spain
Maria Ascierto, PhD
University of Glasgow, United Kingdom
Carlo B. Bifulco, MD
Providence Portland Medical Center, United States
John C. Castle, PhD
Monte Rosa Therapeutics, Switzerland
orcid.org/0000-0001-8697-8955
Alessandra Cesano, MD, PhD
ESSA Pharma Inc., United States
Eric Deutsch, MD, PhD
Gustave Roussy Cancer Campus, France
Jolanda de Vries, PhD
Radboud University Nijmegen, the Netherlands
Elisabeth G.E. de Vries, MD, PhD
University Medical Centre Groningen, the Netherlands
Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM), Canada

Christian H. Ottensmeier, MD, PhD, FRCP
University of Liverpool, United Kingdom
Graham P. Pawelec, PhD
University of Tuebingen, Germany
orcid.org/0000-0002-3600-0163
Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori, Italy
Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg, Germany
orcid.org/0000-0002-5544-4958
Craig L. Slingluff Jr., MD
University of Virginia, United States
orcid.org/0000-0002-6664-4373
Claudio Tripodo, MD
University of Palermo, Italy
orcid.org/0000-0002-0821-6231
Jianda Yuan, MD, PhD
Merck & Co., United States
orcid.org/0000-0003-3551-4434





Oncolytic and Local Immunotherapy
Section Editor
Howard L. Kaufman, MD, FACS
Massachusetts General Hospital, United States
orcid.org/0000-0003-1131-004X

Associate Editors
Darrel J. Irvine, PhD
Massachusetts Institute of Technology, United States
Samuel Rabkin, PhD
Massachusetts General Hospital, United States
orcid.org/0000-0003-2344-2795

K. Dane Wittrup, PhD
Massachusetts Institute of Technology, United States
Dmitriy Zamarin, MD, PhD
Icahn School of Medicine at Mount Sinai, United States
orcid.org/0000-0002-0094-0161

Reviews
Section Editors
Sandra Demaria, MD
Weill Cornell Medical College, United States
orcid.org/0000-0003-4426-0499

Lawrence Fong, MD
Fred Hutchinson Cancer Center, United States
Associate Editors
Ira Mellman, PhD
Medici Therapeutics, United States
orcid.org/0000-0002-6132-7299
James J. Mule, PhD
H. Lee Moffitt Cancer Center & Research Institute, United States
orcid.org/0000-0001-7354-0516


Specialty Editors
Consulting Editor, Special Series and Reviews
Pedro J. Romero, MD†
Novigenix, Switzerland
Consulting Editor
Thomas F. Gajewski, MD, PhD
University of Chicago, United States
Social Media Editors
Kristin G. Anderson, PhD
University of Virginia, United States
Praveen Bommareddy, PhD, MS
Replimune, Inc., United States
Cheng Sun, MD, PhD
University of Science and Technology of China, China
†Founding Editor-in-Chief (2013-2023)
Publishing Team
Head of Portfolio: Kathleen Lyons